Merit Medical Systems, Inc. Revises Earnings Guidance for the Fiscal Year Ended December 31, 2023
October 26, 2023 at 09:05 pm
Share
Merit Medical Systems, Inc. revised earnings guidance for the fiscal year ended December 31, 2023. for the year, the company expects Net sales in the range of $1.242 billion to $1.251 billon against $1.230 billion to $1.244 billion expected previously, GAAP Net income is expected to be in the range of $89 million to $92 million against $76 million to $81 million expected previously and Earnings per share is expected to be in the range of $1.52 to $1.58 against $1.30 to $1.39 expected previously.
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
MERIT MEDICAL SYSTEMS, INC. 
